124.38 0.00 (0.00%)
After hours: 4:17PM EDT
|Bid||124.38 x 800|
|Ask||124.39 x 800|
|Day's Range||123.41 - 124.93|
|52 Week Range||91.75 - 127.06|
|Beta (3Y Monthly)||1.37|
|PE Ratio (TTM)||43.04|
|Earnings Date||Jul 25, 2019|
|Forward Dividend & Yield||0.60 (0.48%)|
|1y Target Est||120.50|
EXTON, Pa., July 11, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release second-quarter 2019 financial results before the market opens on Thursday, July 25, 2019, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. The conference ID is 6143018. An online archive of the broadcast will be available at the West website three hours after the live call and will be available through Thursday, August 1, 2019, by dialing 855-859-2056 (U.S.) or 404-537-3406 (International).
West Pharmaceutical (WST) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Small-caps and large-caps are wildly popular among investors; however, mid-cap stocks, such as West Pharmaceutical...
Hedge funds and other investment firms that we track manage billions of dollars of their wealthy clients' money, and needless to say, they are painstakingly thorough when analyzing where to invest this money, as their own wealth also depends on it. Regardless of the various methods used by elite investors like David Tepper and David […]
West Pharmaceutical Services Inc NYSE:WSTView full report here! Summary * ETFs holding this stock are seeing positive inflows but are weakening * Bearish sentiment is low * Economic output in this company's sector is contracting Bearish sentimentShort interest | PositiveShort interest is extremely low for WST with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting WST. Money flowETF/Index ownership | NegativeETF activity is negative and may be weakening. The net inflows of $926 million over the last one-month into ETFs that hold WST are among the lowest of the last year and appear to be slowing. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managersâ€™ Index (PMI) data, output in the Industrialsis falling. The rate of decline is very significant relative to the trend shown over the past year, and is accelerating. The rate of contraction may ease in the coming months, however. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to firstname.lastname@example.org.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of...
EXTON, Pa., May 22, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, is pleased to announce that the NovaGuard® SA Pro safety system – a single-use accessory for prefilled ISO standard 1mL long staked-needle syringes – has won the India Packaging Awards for Excellence in Enhanced User Experience and Excellence in Packaging Design – Shapes and Structures. In addition, the company announced a new product line extension to its AccelTRA® component program, and showcased thought leadership with presentations at the UBM InnoPack Pharma Conference in Mumbai. The prestigious India Packaging Awards, presented on May 21, 2019 during a ceremony held at the Sahara Star Hotel, are an initiative by UBM to honor the best innovations in the Pharma Packaging space.
With rapid growth projected for the market for wearable drug delivery devices, investors would be wise to consider some of the key players in the business. Two standouts are Boston-area-based Insulet (PODD) and West Pharmaceutical Services (WST), which is headquartered in Exton, Pennsylvania. Warning! GuruFocus has detected 4 Warning Signs with PODD.
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift...
EXTON, Pa., May 8, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a third-quarter 2019 dividend of $0.15 per share. The Company also announced that management will present an overview of the business at three investor conferences in May and June. A live audio webcast of the presentations and a copy of the presentation materials will be accessible from the Company's website at www.westpharma.com/en/investors.
Berkshire Hathaway BRK.B CEO Warren Buffett is probably as famous for analogies like these as he is for his success as an investor. For example, the "really long hill" is arguably the most powerful wealth-creation tool Buffett has, and it's something investors have at their disposal as well: time. Buffett is particularly good at sniffing out businesses with economic moats, or competitive advantages.
On a per-share basis, the Exton, Pennsylvania-based company said it had profit of 73 cents. Earnings, adjusted for restructuring costs, came to 74 cents per share. The results surpassed Wall Street expectations. ...
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , April 25, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter ...
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of West Pharmaceutical Services, Inc. (NYSE:WST) as an investment opportunity by taking the foreast future cash flows of the company and...
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We have processed the filings of the more than 700 world-class investment firms that we track and now have access to the collective wisdom contained in […]
West Pharmaceutical (WST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
EXTON, Pa., April 12, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, today announced the Company's recognition by the Philadelphia Business Journal as a 2019 Faces of Philanthropy award recipient. West received the honor for its ongoing support of Fox Chase Cancer Center during an awards breakfast on April 11, 2019. Organized by the Philadelphia Business Journal, the Faces of Philanthropy awards recognize Philadelphia-based companies who, through philanthropic initiatives with a non-profit organization, have made a large impact on the Philadelphia community through monetary donations, social impact and community involvement.
EXTON, Pa., April 11, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter 2019 financial results before the market opens on Thursday, April 25, 2019, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. The conference ID is 7794502. An online archive of the broadcast will be available at the West website three hours after the live call and will be available through Thursday, May 2, 2019, by dialing 855-859-2056 (U.S.) or 404-537-3406 (International).
Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! Since West Pharmaceutical Services, Inc. (NYSE:WST) released its earnings in December 2018...